UBS analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Buy and lowers the price target from $142 to $113.
UBS Maintains Buy on DaVita, Lowers Price Target to $113
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.